Oxford University spinout PrOXisense secures £330,000 in round led by Parkwalk Advisors for the development of sensors in extreme environments.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Circadian Therapeutics aims to develop therapeutics and diagnostics for modulation of the body's circadian rhythms.
Oxford University forms spinout company to bring fast, cost-effective enzyme development to market.
Oxford University spinouts Genomics and Nanopore partner on utilising handheld nanopore technologies for DNA sequencing.
Mexican superfood startup Azure wins inaugural Humanities Innovation Challenge.
Atopix Therapeutics Limited, a UK biotechnology company with roots back to Oxford University, has been acquired by Italian pharmaceutical firm Chiesi Farmaceutici Spa.
Oxford Cancer Biomarkers, spun out from Oxford University in 2011 to develop tests for personalised medicine in cancer patients, has enrolled its first patient in a clinical study.
Oxford spinout Argonaut Therapeutics is developing cancer drugs which reprogram cancer cells to undergo the body’s natural process of cell death, shrinking tumours. The company will focus on treatments for colorectal cancer and lymphoma.